1-15 of 188

Metabolic Rewiring in DKD: The Role of Tubular Cells
Clinician's RoundtableMetabolic Rewiring in DKD: The Role of Tubular Cells

Exploring Drivers of DKD: Metabolic Rewiring and Mitochondrial Dysfunction
Clinician's RoundtableExploring Drivers of DKD: Metabolic Rewiring and Mitochondrial Dysfunction

Rethinking CKD Screening in the Era of New Therapies
Heart MattersRethinking CKD Screening in the Era of New Therapies

Who Should Be Tested for Chronic Kidney Disease?
Heart MattersWho Should Be Tested for Chronic Kidney Disease?

UACR in Diabetes: A Window Into Cardiorenal Risk
Diabetes DiscourseUACR in Diabetes: A Window Into Cardiorenal Risk

Who’s Most at Risk? Assessing Progression in IgAN
Clinician's RoundtableWho’s Most at Risk? Assessing Progression in IgAN
- advertisement

Navigating Today’s Treatment Options for IgA Nephropathy
Clinician's RoundtableNavigating Today’s Treatment Options for IgA Nephropathy

How Classification Shapes Treatment in FSGS
Clinician's RoundtableHow Classification Shapes Treatment in FSGS

Finerenone in IgAN: A Proteinuria Signal Worth Following
Clinician's RoundtableFinerenone in IgAN: A Proteinuria Signal Worth Following

Green Tea Compound Shows Potential to Protect Podocytes in FSGS
Clinician's RoundtableGreen Tea Compound Shows Potential to Protect Podocytes in FSGS

Could a Simple Blood Test Help Identify Kidney Fibrosis in IgAN?
AudioAbstractsCould a Simple Blood Test Help Identify Kidney Fibrosis in IgAN?

Key CKD Updates from the 2026 NKF Meetings
Clinician's RoundtableKey CKD Updates from the 2026 NKF Meetings
- advertisement

Helping Patients with IgAN Navigate Treatment Decisions
Clinician's RoundtableHelping Patients with IgAN Navigate Treatment Decisions

What the Latest IgAN Clinical Trials Mean for Patient Care
On the Frontlines of IgA NephropathyWhat the Latest IgAN Clinical Trials Mean for Patient Care










































